These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 29121805)
1. Prostate Cancer Xenograft Inhibitory Activity and Pharmacokinetics of Decursinol, a Metabolite of Angelica gigas Pyranocoumarins, in Mouse Models. Wu W; Tang SN; Zhang Y; Puppala M; Cooper TK; Xing C; Jiang C; Lü J Am J Chin Med; 2017; 45(8):1773-1792. PubMed ID: 29121805 [TBL] [Abstract][Full Text] [Related]
2. In vivo anti-cancer activity of Korean Angelica gigas and its major pyranocoumarin decursin. Lee HJ; Lee HJ; Lee EO; Lee JH; Lee KS; Kim KH; Kim SH; Lü J Am J Chin Med; 2009; 37(1):127-42. PubMed ID: 19222117 [TBL] [Abstract][Full Text] [Related]
3. Chemopreventive Effects of Korean Angelica versus Its Major Pyranocoumarins on Two Lineages of Transgenic Adenocarcinoma of Mouse Prostate Carcinogenesis. Tang SN; Zhang J; Wu W; Jiang P; Puppala M; Zhang Y; Xing C; Kim SH; Jiang C; Lü J Cancer Prev Res (Phila); 2015 Sep; 8(9):835-44. PubMed ID: 26116406 [TBL] [Abstract][Full Text] [Related]
4. Pyranocoumarin Tissue Distribution, Plasma Metabolome and Prostate Transcriptome Impacts of Sub-Chronic Exposure to Korean Angelica Supplement in Mice. Zhang J; Li L; Tang S; Zhang Y; Markiewski M; Xing C; Jiang C; Lü J Am J Chin Med; 2016; 44(2):321-53. PubMed ID: 27080944 [TBL] [Abstract][Full Text] [Related]
5. Interception Targets of Tang SN; Jiang P; Kim S; Zhang J; Jiang C; Lü J Cancer Prev Res (Phila); 2021 Jun; 14(6):635-648. PubMed ID: 33648943 [TBL] [Abstract][Full Text] [Related]
6. Quantitative determination of decursin, decursinol angelate, and decursinol in mouse plasma and tumor tissue using liquid-liquid extraction and HPLC. Li L; Zhang J; Shaik AA; Zhang Y; Wang L; Xing C; Kim SH; Lü J Planta Med; 2012 Feb; 78(3):252-9. PubMed ID: 22116603 [TBL] [Abstract][Full Text] [Related]
7. Natural Korean Medicine Dang-Gui: Biosynthesis, Effective Extraction and Formulations of Major Active Pyranocoumarins, Their Molecular Action Mechanism in Cancer, and Other Biological Activities. Reddy CS; Kim SC; Hur M; Kim YB; Park CG; Lee WM; Jang JK; Koo SC Molecules; 2017 Dec; 22(12):. PubMed ID: 29215592 [No Abstract] [Full Text] [Related]
8. Single oral dose pharmacokinetics of decursin, decursinol angelate, and decursinol in rats. Li L; Zhang J; Xing C; Kim SH; Lü J Planta Med; 2013 Mar; 79(3-4):275-80. PubMed ID: 23364885 [TBL] [Abstract][Full Text] [Related]
9. Anti-cancer and other bioactivities of Korean Angelica gigas Nakai (AGN) and its major pyranocoumarin compounds. Zhang J; Li L; Jiang C; Xing C; Kim SH; Lü J Anticancer Agents Med Chem; 2012 Dec; 12(10):1239-54. PubMed ID: 22583405 [TBL] [Abstract][Full Text] [Related]
10. Anti-tumor activities of decursinol angelate and decursin from Angelica gigas. Lee S; Lee YS; Jung SH; Shin KH; Kim BK; Kang SS Arch Pharm Res; 2003 Sep; 26(9):727-30. PubMed ID: 14560921 [TBL] [Abstract][Full Text] [Related]
11. Single oral dose pharmacokinetics of decursin and decursinol angelate in healthy adult men and women. Zhang J; Li L; Hale TW; Chee W; Xing C; Jiang C; Lü J PLoS One; 2015; 10(2):e0114992. PubMed ID: 25695490 [TBL] [Abstract][Full Text] [Related]
12. A novel class of pyranocoumarin anti-androgen receptor signaling compounds. Guo J; Jiang C; Wang Z; Lee HJ; Hu H; Malewicz B; Lee HJ; Lee JH; Baek NI; Jeong JH; Kim DK; Kang KS; Kim SH; Lu J Mol Cancer Ther; 2007 Mar; 6(3):907-17. PubMed ID: 17363485 [TBL] [Abstract][Full Text] [Related]
13. Effects of Angelica gigas Nakai on the production of decursin- and decursinol angelate-enriched eggs. Fontamillas GAD; Kim SW; Kim HU; Kim SJ; Kim JG; Park TS; Park BC J Sci Food Agric; 2019 Apr; 99(6):3117-3123. PubMed ID: 30536922 [TBL] [Abstract][Full Text] [Related]
14. Simultaneous Determination of Decursin, Decursinol Angelate, Nodakenin, and Decursinol of Kim SJ; Ko SM; Choi EJ; Ham SH; Kwon YD; Lee YB; Cho HY Molecules; 2018 Apr; 23(5):. PubMed ID: 29701699 [TBL] [Abstract][Full Text] [Related]
15. Nanocomposites based on Soluplus and Angelica gigas Nakai extract fabricated by an electrohydrodynamic method for oral administration. Lee JJ; Nam S; Park JH; Lee SY; Jeong JY; Lee JY; Kang WS; Yoon IS; Kim DD; Cho HJ J Colloid Interface Sci; 2016 Dec; 484():146-154. PubMed ID: 27599383 [TBL] [Abstract][Full Text] [Related]
16. Lü J; Jiang C; Schell TD; Joshi M; Raman JD; Xing C Am J Chin Med; 2022; 50(6):1475-1527. PubMed ID: 35876033 [No Abstract] [Full Text] [Related]
17. A synthetic decursin analog with increased in vivo stability suppresses androgen receptor signaling in vitro and in vivo. Zhang Y; Shaik AA; Xing C; Chai Y; Li L; Zhang J; Zhang W; Kim SH; Lü J; Jiang C Invest New Drugs; 2012 Oct; 30(5):1820-9. PubMed ID: 21870073 [TBL] [Abstract][Full Text] [Related]
18. Cytochrome P450 Isoforms in the Metabolism of Decursin and Decursinol Angelate from Korean Angelica. Zhang J; Li L; Tang S; Hale TW; Xing C; Jiang C; Lü J Am J Chin Med; 2015; 43(6):1211-30. PubMed ID: 26394652 [TBL] [Abstract][Full Text] [Related]
19. In vitro metabolism of pyranocoumarin isomers decursin and decursinol angelate by liver microsomes from man and rodents. Li L; Zhang J; Xing C; Kim SH; Jiang C; Lü J Planta Med; 2013 Nov; 79(16):1536-44. PubMed ID: 24026903 [TBL] [Abstract][Full Text] [Related]
20. Potent antiandrogen and androgen receptor activities of an Angelica gigas-containing herbal formulation: identification of decursin as a novel and active compound with implications for prevention and treatment of prostate cancer. Jiang C; Lee HJ; Li GX; Guo J; Malewicz B; Zhao Y; Lee EO; Lee HJ; Lee JH; Kim MS; Kim SH; Lu J Cancer Res; 2006 Jan; 66(1):453-63. PubMed ID: 16397261 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]